41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
3512552
319423
2
Public Timelines
FAQ

jan 1, 1998 - Trastuzumab

Description:

For the treatment of women with HER2-positive metastatic breast cancer, the Food and Drug Administration (FDA) recommends trastuzumab, a monoclonal antibody that inhibits cancer cells that overproduce the HER2 protein.

Added to timeline:

14 Nov 2019
0
0
309

Date:

jan 1, 1998
Now
~ 28 years ago